Cannabis Bioscience International Holdings (CBIH) Stock Price, News & Analysis
Company Description
Cannabis Bioscience International Holdings (OTC Link: CBIH) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.7M.
CBIH has declined 60.0% over the past year. Shares last traded at $0.0001.
For FY2025, Cannabis Bioscience International Holdings reported revenue of $303K with net income of -$549K and diluted earnings per share of $0.00. The company operates at a net profit margin of -181.1%.
This page collects what Stock Titan holds for CBIH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cannabis Bioscience International Holdings (CBIH) stock last closed at $0.0001. Over the past 12 months, the stock has lost 60.0%. At a market capitalization of $1.7M, CBIH is classified as a micro-cap stock with approximately 11.6B shares outstanding.
CBIH Rankings
Latest News
Cannabis Bioscience International Holdings has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include partnership, clinical trial, conferences. View all CBIH news →
SEC Filings
Cannabis Bioscience International Holdings has filed 5 recent SEC filings, including 2 Form 10-Q, 2 Form NT 10-Q, 1 Form 144. The most recent filing was submitted on May 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CBIH SEC filings →
Financial Highlights
Cannabis Bioscience International Holdings generated $303K in revenue in FY2025, retaining a 86.8% gross margin, operating income reached -$421K (-139.1% operating margin), and net income was -$549K, reflecting a -181.1% net profit margin. Diluted earnings per share stood at $0.00. The company generated -$330K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Cannabis Bioscience International Holdings (CBIH) currently stands at 759.8 thousand shares, up 24.0% from the previous reporting period, representing 0.0% of the float. Since August 2025, short interest has increased by 4220733.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Cannabis Bioscience International Holdings (CBIH) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CBIH Company Profile & Sector Positioning
Cannabis Bioscience International Holdings (CBIH) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CBIH often look at related companies in the same sector, including Marijuana Inc. (MAJI), Filament Health (FLHLF), Crescita Therape (CRRTF), Revive Therapeutics Ltd (RVVTF), and Pharmacielo (PCLOF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CBIH's relative position within its industry.